Blood Neurofilament Light in Progressive Multiple Sclerosis: Post Hoc Analysis of 2 Randomized Controlled Trials

BACKGROUND AND OBJECTIVES: To investigate the potential of plasma neurofilament light (pNfL) as a biomarker of disease progression and treatment response in progressive multiple sclerosis (PMS) with and without acute disease activity. METHODS: A post hoc blinded analysis of pNfL levels in 2 placebo-...

Descripción completa

Detalles Bibliográficos
Autores principales: Leppert, David, Kropshofer, Harald, Häring, Dieter A., Dahlke, Frank, Patil, Ashwini, Meinert, Rolf, Tomic, Davorka, Kappos, Ludwig, Kuhle, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263182/
https://www.ncbi.nlm.nih.gov/pubmed/35379762
http://dx.doi.org/10.1212/WNL.0000000000200258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263182/
https://www.ncbi.nlm.nih.gov/pubmed/35379762
http://dx.doi.org/10.1212/WNL.0000000000200258

Ejemplares similares